News

First patients to test new glaucoma device

Clinical
​Three patients are first in the UK to test a new surgical implant

Three patients have become the first in the UK to test a new surgical implant to drain excess eye fluid caused by glaucoma at Manchester Royal Eye Hospital (MREH).

Named eyeWatch, the device was the first of its kind to allow a post-operative flow adjustment in clinic and reduced the risk of under or over-drainage to lessen side effects and the need for further surgery.

Rheon Medical has manufactured the device, which is inserted through the skin at the front of the eye and into the white area. It is then connected to a drainage tube which moves excess fluid to the back of the eye where it can be reabsorbed. There is a built-in magnetically controlled flow mechanism that opens and closes the device based on eye pressure using a magnetic pen.

Register now to continue reading

Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.

Register

Already have an account? Sign in here